Last edition
News about Industrial talks
Powered by Honeywell, GPACTS 2026 will feature senior leaders from Alkem Laboratories, Dr. Reddy’s Laboratories, Wockhardt, Granules India and Biological E.
Industrial talks | 26/08/2026 | By News Bureau
Union MoS Anupriya Patel Calls for India to Become Laboratory of the World
Union Minister of State (MoS) Anupriya Patel urges India to become the ‘Laboratory of the World’ as IIM-A Healthcare Summit 2026 explores Artificial Intelligence (AI)-driven drug discovery and healthcare.
Industrial talks | 24/08/2026 | By News Bureau
Karnataka FDA’s Drugs Control Wing has busted an alleged counterfeit drug manufacturing and repackaging unit near Bidadi, seizing pharmaceutical products and related materials valued at more than INR 5 crore.
Industrial talks | 19/08/2026 | By News Bureau
Pfizer and Valneva's Lyme Disease Vaccine Candidate Moves to EMA Review
Pfizer and Valneva’s investigational Lyme disease vaccine PF-07307405 has received EMA validation for its Marketing Authorization Application, triggering the European regulatory review.
Industrial talks | 17/08/2026 | By News Bureau
CPHI Milan 2026 Unveils Four Specialist Zones to Accelerate Pharma Manufacturing Innovation
CPHI Milan 2026 will introduce four specialist zones covering AI & technology, cold-chain logistics, labelling and contamination control, creating dedicated platforms for pharma companies to connect with innovators addressing manufacturing, compliance and supply-chain challenges.
Industrial talks | 17/08/2026 | By News Bureau
Maharashtra FDA Warns Drug Applicants Against Unauthorised Agents, Intermediaries
Maharashtra FDA has warned drug manufacturers, wholesalers and retailers against unauthorised agents demanding money for licences and urged applicants to use the official online system directly.
Industrial talks | 14/08/2026 | By News Bureau
Lupin's US Business May Moderate After Strong Q1, Says Equirus Securities
Equirus Securities expects Lupin’s US business to moderate amid rising competition, while new launches and expanding chronic and international portfolios could support overall growth.
Industrial talks | 14/08/2026 | By News Bureau
Zydus Lifesciences Reports 22 Percent Revenue Growth in Q1 FY27, Advances Innovation Pipeline
Zydus Lifesciences began FY27 with strong double-digit growth, driven by robust performance across India and international formulations, alongside continued progress in manufacturing quality and biosimilar innovation.
Industrial talks | 12/08/2026 | By News Bureau
Biodeal Pharmaceuticals Secures INR 385 Crore Growth Investment from RMB Capitalworks
Biodeal Pharmaceuticals raises INR 385 crore from RMB Capitalworks to accelerate specialty pharma expansion, strengthen manufacturing capabilities and expand its presence across global regulated markets.
Industrial talks | 11/08/2026 | By News Bureau
WHO SEARN Recognises IPC as Regional Centre of Excellence
Indian Pharmacopoeia Commission (IPC) has been recognised by WHO SEARN as a Regional Centre of Excellence for pharmacovigilance and medicines quality.
Industrial talks | 06/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy